Lori McIntyre

1.6k total citations · 1 hit paper
8 papers, 700 citations indexed

About

Lori McIntyre is a scholar working on Oncology, Pathology and Forensic Medicine and Infectious Diseases. According to data from OpenAlex, Lori McIntyre has authored 8 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 2 papers in Pathology and Forensic Medicine and 1 paper in Infectious Diseases. Recurrent topics in Lori McIntyre's work include CAR-T cell therapy research (7 papers), Lymphoma Diagnosis and Treatment (2 papers) and Beetle Biology and Toxicology Studies (1 paper). Lori McIntyre is often cited by papers focused on CAR-T cell therapy research (7 papers), Lymphoma Diagnosis and Treatment (2 papers) and Beetle Biology and Toxicology Studies (1 paper). Lori McIntyre collaborates with scholars based in United States, Malaysia and Italy. Lori McIntyre's co-authors include Steven A. Rosenberg, Richard M. Sherry, James C. Yang, James N. Kochenderfer, Stephanie L. Goff, Steven A. Feldman, Kathryn M. Cappell, Danielle Vanasse, Tangying Lu and John M. Rossi and has published in prestigious journals such as Journal of Clinical Oncology, Molecular Therapy and Journal of Immunotherapy.

In The Last Decade

Lori McIntyre

7 papers receiving 683 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma

2019 301 citations Stephanie L. Goff, Richard A. Morgan et al. Journal of Immunotherapy profile →

Peers

Lori McIntyre

ONCOL

BE

IMMUN

GENET

MB

Elizabeth Halton United States

Ian R. Hardy United States

Barbara Pender United States

Jeff Aycock United States

Parisa Malekzadeh United States

Raghuveer Ranganathan United States

Meg Elias United States

Stefanie Lesch Germany

Sanfang Tu China

Bipulendu Jena United States

Elizabeth Halton United States

Lori McIntyre

555 ×0.9

ONCOL

141 ×0.6

BE

129 ×0.7

IMMUN

187 ×1.0

GENET

117 ×0.7

MB

Citations per year, relative to Lori McIntyre Lori McIntyre (= 1×) peers Elizabeth Halton

Countries citing papers authored by Lori McIntyre

Since Specialization

Citations

This map shows the geographic impact of Lori McIntyre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori McIntyre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori McIntyre more than expected).

Fields of papers citing papers by Lori McIntyre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori McIntyre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori McIntyre. The network helps show where Lori McIntyre may publish in the future.

Co-authorship network of co-authors of Lori McIntyre

This figure shows the co-authorship network connecting the top 25 collaborators of Lori McIntyre. A scholar is included among the top collaborators of Lori McIntyre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori McIntyre. Lori McIntyre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

McIntyre, Lori, Stephanie L. Goff, James C. Yang, et al.. (2025). Survival after anti-CD19 CAR T-cell therapy for B-cell non-Hodgkin lymphoma and CLL with 10 years of follow-up. Blood Advances. 9(20). 5362–5366.

2.

Cappell, Kathryn M., Richard M. Sherry, James C. Yang, et al.. (2020). Long-term follow-up of anti-CD19 CAR T-cell therapy for B-cell lymphoma and chronic lymphocytic leukemia.. Journal of Clinical Oncology. 38(15_suppl). 3012–3012. 4 indexed citations

3.

Cappell, Kathryn M., Richard M. Sherry, James C. Yang, et al.. (2020). Long-Term Follow-Up of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy. Journal of Clinical Oncology. 38(32). 3805–3815. 179 indexed citations

4.

Goff, Stephanie L., Richard A. Morgan, James C. Yang, et al.. (2019). Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma. Journal of Immunotherapy. 42(4). 126–135. 301 indexed citations breakdown →

5.

Kochenderfer, James N., Robert Somerville, Tangying Lu, et al.. (2017). Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy. Molecular Therapy. 25(10). 2245–2253. 199 indexed citations

6.

Kochenderfer, James N., Robert Somerville, Tangying Lu, et al.. (2016). Anti-CD19 chimeric antigen receptor T cells preceded by low-dose chemotherapy to induce remissions of advanced lymphoma.. Journal of Clinical Oncology. 34(18_suppl). LBA3010–LBA3010. 12 indexed citations

7.

Kochenderfer, James N., Robert Somerville, Tangying Lu, et al.. (2016). Anti-CD19 chimeric antigen receptor T cells preceded by low-dose chemotherapy to induce remissions of advanced lymphoma.. Journal of Clinical Oncology. 34(15_suppl). LBA3010–LBA3010. 4 indexed citations

8.

Ohnmacht, Galen A., Giao Q. Phan, Sharon Mavroukakis, et al.. (2001). A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effect of Nystatin on the Development of Oral Irritation in Patients Receiving High-Dose Intravenous Interleukin-2. Journal of Immunotherapy. 24(2). 188–192. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact